D-22
Today 2026-03-12
LOGO
Scientific Program
|
April 3 (Fri) 11:30-12:10 |
Mini-Oral I
|
Hall D |
|---|---|---|
| Chair(s) |
Chi-Heum Cho (Keimyung University) Sunghoon Kim (Yonsei University) |
|
| 11:30-11:35 |
Artificial intelligence-based prediction of ovarian cancer using clinico-genetic data: A multicentre development and external comparison study
Seong Eun Bak (The Catholic University of Korea) |
|
| 11:35-11:38 | Floor Discussion | |
| 11:38-11:43 |
Genomic features and HRD prevalence in Korean high-grade serous ovarian cancer
Hyun Park (CHA University) |
|
| 11:43-11:46 | Floor Discussion | |
| 11:46-11:51 |
Real-world effectiveness of first-line niraparib maintenance therapy in Korean patients with advanced ovarian cancer: A multicenter retrospective cohort study
Jeong-Yeol Park (Asan Medical Center) |
|
| 11:51-11:54 | Floor Discussion | |
| 11:54-11:59 |
First-line niraparib maintenance in BRCA wild-type, low-risk advanced ovarian cancer: The POLO trial
Se Ik Kim (Seoul National University) |
|
| 11:59-12:02 | Floor Discussion | |
| 12:02-12:07 |
Mechanistic insights into PLK1 inhibition in ovarian cancer using PROTAC-based therapeutic strategies
Taewan Kim (Soonchunhyang University) |
|
| 12:07-12:10 | Floor Discussion | |
|
April 3 (Fri) 12:10-12:50 |
Industry Session IV - Takeda
|
Hall D |
|---|---|---|
| Chair(s) |
Suk-Joon Chang (Ajou Unviersity) |
|
| 12:10-12:40 |
ong-term efficacy and real-world impact of Niraparib as first-line maintenance in advanced ovarian cancer: Insights from the PRIMA study and clinical evidence
Hyun-Woong Cho (University of Ulsan) |
|
| 12:40-12:50 | Floor discussion | |
|
April 3 (Fri) 12:50-13:30 |
Mini-Oral II
|
Hall D |
|---|---|---|
| Chair(s) |
Yong Beom Kim (Seoul National University) Chel Hun Choi (Sungkyunkwan University) |
|
| 12:50-12:55 |
Triweekly versus weekly carboplatin plus paclitaxel as frontline treatment for advanced endometrial cancer
Shao-Jing Wang (Taichung Veterans General Hospital) |
|
| 12:55-12:58 | Floor Discussion | |
| 12:58-13:03 |
Adjuvant sandwich therapy is associated with improved survival in stage III–IVA endometrial cancer: A network meta-analysis
Xinyi Chen (Sun Yat-Sen University Cancer Center) |
|
| 13:03-13:06 | Floor Discussion | |
| 13:06-13:11 |
Metabolic syndrome promotes endometrial cancer by Oleic acid-mediated polyamine accumulation
Lirong Zhai (Peking University People's Hospital) |
|
| 13:11-13:14 | Floor Discussion | |
| 13:14-13:19 |
Development and optimization of a deep learning model for the diagnosis of endometrial cancer in ultrasound images
Hye-Yeon Moon (Korea University) |
|
| 13:19-13:22 | Floor Discussion | |
| 13:22-13:27 |
Hormone receptor expression stratifies recurrence risk in no specific molecular profile endometrial cancer: A retrospective cohort study
Jooeun Kim (Korea University) |
|
| 13:27-13:30 | Floor Discussion | |
|
April 3 (Fri) 15:50-16:30 |
Mini-Oral III
|
Hall D |
|---|---|---|
| Chair(s) |
Sooyoung Hur (The Catholic University of Korea) Chul Min Park (Jeju National University) |
|
| 15:50-15:55 |
Development of an on-device AI model for cervical cancer screening using colposcopy images
Eun Taeg Kim (Kosin University) |
|
| 15:55-15:58 | Floor Discussion | |
| 15:58-16:03 |
Post–primary treatment hormone replacement therapy and survival in women with cervical cancer: A Korean nationwide cohort study
Banghyun Lee (Inha University) |
|
| 16:03-16:06 | Floor Discussion | |
| 16:06-16:11 |
The radiosensitivity index (RSI): A patient-derived organoid platform for predicting radioresistance in cervical cancer
Young Joo Lee (Kyung Hee University) |
|
| 16:11-16:14 | Floor Discussion | |
| 16:14-16:19 |
Incidence trends and survival of cervical cancer: A population-based study on thai cancer registry database
Apirak Nguanboonmak (Makarak Hospital of Thammasat University) |
|
| 16:19-16:22 | Floor Discussion | |
| 16:22-16:27 |
Preoperative prediction model for the necessity of postoperative radiotherapy in early-stage cervical cancer patients undergoing primary radical surgery
Chayanid Detwongya (Chiang Mai University Hospital) |
|
| 16:27-16:30 | Floor Discussion | |
|
April 3 (Fri) 16:30-17:10 |
Mini-Oral IV
|
Hall D |
|---|---|---|
| Chair(s) |
Jong-Min Lee (Kyung Hee University) Jaeman Bae (Hanyang University) |
|
| 16:30-16:35 |
HPV vaccination is associated with favorable vaginal microbiome profiles and altered HPV genotype landscapes
Jong Mi Kim (Kyungpook National University) |
|
| 16:35-16:38 | Floor Discussion | |
| 16:38-16:43 |
Dietary arginine restriction exploits DNMT3B–ASS1–driven arginine auxotrophy and mTORC1 suppressed autophagy to overcome niraparib resistance in ovarian cancer
Haoyu Wang (Peking Union Medical College Hospital) |
|
| 16:43-16:46 | Floor Discussion | |
| 16:46-16:51 |
Aprepitant-based triple antiemetic regimen for prevention of chemotherapy-induced nausea and vomiting in gynecologic cancer patients receiving paclitaxel–carboplatin: Results of a phase III randomized trial
Dengfeng Wang (Sichuan Clinical Research Center for Cancer) |
|
| 16:51-16:54 | Floor Discussion | |
| 16:54-16:59 |
Complete cytoreduction is feasible and prognostic in selected stage IV epithelial ovarian cancer
Yusuke Toyohara (Cancer Institute Hospital of JFCR) |
|
| 16:59-17:02 | Floor Discussion | |
| 17:02-17:07 |
B7-H4 blockade reverses T cell exhaustion and enhances the efficacy of Vγ9Vδ2 T cell adoptive therapy in reprogramming the immune microenvironment of ovarian cancer
Ying Zhou (The First Affiliated Hospital of Soochow University) |
|
| 17:07-17:10 | Floor Discussion | |
SPONSORS
